Clinical Performance Study Plan Development Services
Elexes helps medical device and IVD manufacturers build clear, regulator-ready clinical performance study plans that align with IVDR, GCP, and broader evidence expectations. From study objectives and endpoints to methodology, data integrity, and documentation traceability, our team develops plans that reduce review risk and support smoother submissions across global markets.
Our Clinical Performance Study Plan Development Services
Strategic planning, documentation, and regulatory support for defensible clinical performance study plans and related evidence packages.
Study Plan Development
We develop structured clinical performance study plans that define objectives, endpoints, methodology, populations, data handling, and documentation requirements for regulatory use.
Clinical Evidence Strategy
Our team aligns study planning with broader clinical evidence expectations, helping manufacturers determine what data is needed and how it should support submissions.
Pre-submission Support
We prepare manufacturers for regulator interactions by refining study rationale, documentation packages, and key questions before formal submission or authority engagement.
Submission Readiness
Elexes reviews study-related documentation for completeness, consistency, and traceability so teams can move forward with greater confidence and fewer avoidable gaps.
IVDR Performance Planning
For IVD manufacturers, we support performance study planning aligned with IVDR expectations, including evidence structure, reportability considerations, and regulatory positioning.
Protocol Review Support
We review draft protocols and supporting documents to strengthen scientific rationale, operational clarity, and regulatory defensibility before execution begins.
Regulatory-Ready Planning
Build Study Plans Regulators Can Follow
A strong clinical performance study plan does more than outline activities—it creates a defensible framework for generating credible evidence. Elexes helps manufacturers structure study objectives, endpoints, methodology, data controls, and documentation so the final plan supports regulatory expectations, internal execution, and downstream submission readiness. Our approach reduces ambiguity, strengthens traceability, and helps teams avoid costly rework later.
Trusted By Manufacturers
Success Stories
Supporting evidence planning and regulatory documentation for medical device and IVD teams worldwide.
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Having Elexes as our import-export expert was a great choice. Elexes’ team answered all our questions and guided us through every step.”
Linda Pan
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Accurate and amazing! Their regulatory-compliant fact sheets for multiple products enabled us to sell domestically and internationally without issues. Their work had an impressive turnaround time.”
Elizabeth W
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for disciplined planning, regulatory depth, and practical execution support.
Deep Expertise
50+ years of collective experience across clinical, regulatory, and quality documentation requirements.
Global Coverage
Support across FDA, EU, TGA, Health Canada, and other international regulatory frameworks.
End-to-End Support
From evidence strategy through submission readiness, we support the full documentation lifecycle.
Proven Results
250+ successful projects and a 90% audit clearance rate reflect disciplined execution.
Meet The Elexes Team
Experienced specialists in regulatory, quality, and clinical documentation.
Elexes Medical Consulting Pvt. Ltd. has built its reputation by helping medical device, IVD, and digital health companies navigate complex regulatory and clinical documentation demands with confidence. The company supports manufacturers across global markets with services spanning regulatory approvals, clinical trial documentation, quality system support, and post-market compliance. Backed by 50+ years of collective experience, the Elexes team brings cross-functional expertise in regulatory affairs, quality assurance, and clinical evidence strategy. With 250+ successful projects completed across 200+ product types and support delivered to more than 100 global clients, Elexes focuses on practical, defensible solutions that reduce submission risk, improve readiness, and help organizations move from development to market with stronger documentation foundations.
200+ Product TypesExperience spanning a wide range of device categories.90% Audits ClearedReflects strong quality and compliance execution.250+ Successful ProjectsDelivered across diverse regulatory and documentation engagements.
Frequently Asked Questions
What is a clinical performance study plan?
A clinical performance study plan is a structured document that explains how a manufacturer will generate and evaluate clinical performance data for a device, especially an IVD. It typically defines the study objective, intended population, endpoints, methodology, statistical approach, data management, monitoring, and documentation controls. The plan helps ensure the study is scientifically sound, operationally clear, and suitable for regulatory review.
What is a clinical study plan?
A clinical study plan is the roadmap for conducting a clinical investigation or performance study. It outlines why the study is being done, what evidence will be collected, how subjects or samples will be selected, what procedures will be followed, and how results will be analyzed. In regulated industries, it also supports compliance, traceability, and consistency across teams, sites, and submission documents.
What is the protocol for a clinical study?
The protocol is the core operational and scientific document for a clinical study. It describes the study design, objectives, eligibility criteria, procedures, endpoints, monitoring methods, safety considerations, and statistical analysis plan. In practice, the protocol must be detailed enough for investigators, sponsors, and reviewers to understand exactly how the study will be conducted and how the resulting data will support regulatory or clinical claims.
Why is a clinical performance study plan important for regulatory submissions?
A well-developed study plan helps regulators see that the evidence generation approach is intentional, traceable, and aligned with the device’s intended use and claims. It reduces the risk of unclear endpoints, weak methodology, inconsistent data collection, or missing documentation. Strong planning also improves internal execution by aligning clinical, regulatory, quality, and biostatistics teams before the study begins.
What should be included in a clinical performance study plan?
A complete plan usually includes study objectives, rationale, intended use context, endpoints, study design, inclusion and exclusion criteria, sample strategy, data collection methods, monitoring approach, statistical considerations, risk controls, and documentation responsibilities. Depending on the device and market, it may also address GCP alignment, data integrity expectations, adverse event handling, and links to broader clinical evidence or performance evaluation requirements.
How does Elexes support clinical performance study plan development?
Elexes supports manufacturers by drafting or reviewing study plans, aligning them with applicable regulatory frameworks, and ensuring the documentation is coherent, defensible, and submission-ready. The team helps define objectives, endpoints, methodology, and evidence strategy while checking for consistency with risk management, intended use, and broader regulatory documentation. This reduces avoidable gaps before study execution or authority review.
Can you help align study plans with IVDR and global regulatory expectations?
Yes. Elexes supports study planning in the context of IVDR, FDA, TGA, Health Canada, and other global frameworks where clinical or performance evidence is required. The goal is to build a plan that is not only scientifically appropriate but also usable within the target submission pathway. That includes documentation structure, evidence traceability, and alignment with related technical and quality records.
When should a manufacturer start developing a clinical performance study plan?
The study plan should be developed before study execution begins and ideally early enough to influence evidence strategy, resource planning, and regulatory decision-making. Starting early allows teams to identify data gaps, refine endpoints, confirm feasibility, and align internal stakeholders. It also helps avoid protocol amendments, duplicated work, and evidence packages that fail to support the intended submission or market access strategy.
Still Have Questions About Study Planning?
Talk with our experts about your clinical evidence and documentation needs.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise.
MDSAP
Supports multi-market audit readiness.
GCP
Clinical study compliance knowledge.
